Godrej Agrovet Limited has today reported its financial performance for the quarter ended June 30, 2021
HIGHLIGHTS OF FINANCIAL PERFORMANCE (Q1FY22)
(Rs. in crore)
Particulars
|
Standalone
|
Consolidated
|
||||
Q1FY22 |
Q1FY21 |
%increase/ |
Q1FY22 |
Q1FY21 |
%increase/ |
|
Total Income |
1,559.5 |
1,163.6 |
34.0% |
2,003.2 |
1,562.4 |
28.2% |
Earnings before Depreciation, |
160.9 |
142.3 |
13.1% |
180.0 |
174.2 |
3.3% |
Profit Before Tax (PBT) |
128.3 |
113.0 |
13.5% |
137.5 |
134.4 |
2.3% |
Net Profit after tax (PAT) |
95.4 |
86.5 |
10.3% |
104.7 |
100.6 |
4.1% |
Consolidated PBT includes profit from share of associate/JVs
Managing Directors Comments
Commenting on the performance of the Q1FY21, Mr. B. S. Yadav, Managing Director, Godrej Agrovet Limited, said:
I am pleased to share with you the financials of Godrej Agrovet Limited for the quarter ended June 30, 2021. Consolidated total income was Rs.2,003 crore, registering a growth of 28.2% year-on-year. Consolidated profit before tax was Rs.137 crore, registering a growth of 2.3% year-on-year.
It was one of the best quarterly performance for the animal feed business with segment results growing by 32.5%, supported by volume growth and R&D benefits realization. Vegetable oil benefitted from higher oil prices and posted segment results of Rs.32.6 crore which was a 4X increase year-on-year. Standalone crop protection business also registered a modest growth of 5.9% in segment results. However, Astec LifeSciences EBITDA declined by 13.7% due to lower export sales and higher input cost inflation. In the food businesses, demand recovery seen in the previous quarter was impacted by micro-lockdowns in the current quarter. Profitability was further impacted by low end-product price. Our dairy subsidiary, Creamline dairy registered an EBITDA loss of Rs.3.1 crore due to increase in the procurement costs. Our poultry and poultry products business faced a challenging quarter with low end-product prices on one hand and high input costs on the other hand. As a result, Godrej Tyson Foods Limited, registered a marginal loss at the EBITDA level.
The second wave of COVID-19 has significantly impacted economic recovery seen in the preceding quarter, especially in rural India which had a much stricter lockdown. Further, after a good start to the south-west monsoon, there was a long gap that resulted in lower Kharif sowing. However, recovery has gained pace from July-21 onwards with macro-economic indicators improving m-o-m and rainfall in July-21 covering most parts of India. We expect recovery to be faster in the second half of the year, as vaccination percentage increases leading to the normalization of business activities.
At Godrej Agrovet we are ensuring business continuity along with employee safety. We are conducting a nation-wide vaccination drive for company employees & families, contractual workforce, trade partners. Nearly 88% of our employees have received the first dose and we will cover the entire employee base shortly. During these tough times we are also committed to serve society. Our CSR strategy has been pivoted to strengthen the public healthcare system in order to address the challenges faced by rural communities. We provided medical material and health equipments at various locations and helped the Government effort towards combating the pandemic.
Segment-wise business highlights
Animal Feed
Vegetable Oil
Crop Protection (standalone)
Astec:
Dairy
Godrej Tyson Foods Limited
ACI Godrej Agrovet Private Limited, Bangladesh
About Godrej Agrovet Limited
Godrej Agrovet Limited (GAVL) is a diversified, Research & Development focused agri- business Company, dedicated to improving the productivity of Indian farmers by innovating products and services that sustainably increase crop and livestock yields. GAVL holds leading market positions in the different businesses in which it operates - Animal Feed, Crop Protection, Oil Palm, Dairy and Poultry and Processed Foods.
GAVL has a pan India presence with sales of over a million tonnes annually of high quality animal feed and cutting-edge nutrition products for cattle, poultry, aqua feed and specialty feed. Our teams have worked closely with Indian farmers to develop large Oil Palm Plantations which is helping in bridging the demand and supply gap of edible oil in India. In the crop protection segment, the company meets the niche requirement of farmers through innovative agrochemical offerings. GAVL through its subsidiary Astec Life Sciences Limited, is also a business-to-business (B2B) focused bulk manufacturer of fungicides. In Dairy and Poultry and Processed Foods, the company operates through its subsidiaries Creamline Dairy Products Limited and Godrej Tyson Foods Limited. Apart from this, GAVL also has a joint venture with the ACI group of Bangladesh for animal feed business in Bangladesh.
For more information on the Company, please log on to www.godrejagrovet.com.
Disclaimer: “Some of the statements in this communication may be ‘forward looking statements’ within the meaning of applicable laws and regulations. Actual results might differ substantially from those expressed or implied. Important developments that could affect the Company’s operations include changes in industry structure, significant changes in political and economic environment in India and overseas, tax laws, import duties, litigation and labour relations.”
Godrej Agrovet Limited
"Godrej One", 3rd Floor,
Pirojshanagar,
Eastern Express Highway,
Vikhroli (East),
Mumbai-400079, India
CIN: L15410MH1991PLC135359
Mr. S. Varadaraj
Godrej Agrovet Limited
Tel No.: +91 22 2519 4864
Fax No.: +91 22 2519 5124
Email: gavlinvestors@godrejagrovet.com / s.varadaraj@godrejagrovet.com
Website: www.godrejagrovet.com
Ms. Chhavi Agarwal
Godrej Agrovet Limited
Tel No.: +91 22 2519 4646
Fax No.: +91 22 2519 5124
Email: gavlinvestors@godrejagrovet.com / chhavi.agarwal@godrejagrovet.com
Website: www.godrejagrovet.com
Mr. Anoop Poojari / Mr. Devrishi Singh
CDR India
Tel No.: +91 22 6645 1211 / 1218
Fax No. +91 22 6645 1213
Email: anoop@cdr-india.com / devrishi@cdr-india.com